 pharmacokinetics plasminogen activator rabbit pharmacokinetics activated latent forms plasminogen activator fibrosarcoma cells nonglycosylated form human yeast expression system rabbit immunologic assay specific human guanidine HCI total plasma volume intravenous bolus administration biphasic clearance pattern initial beta phases minutes initial beta phases minutes Similar results activity plasma trace amounts pharmacokinetic behavior endogenous liver main site clearance latent different pharmacokinetic profile latent circulation minutes minutes difference clearance behavior latent ability activated latent high-molecular-weight complexes plasma binding factors vitro vivo fibrinolytic balance prothrombotic state rapid clearance important control mechanism circulating levels key component fibrinolytic pathway